XML 54 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of fair value of assets and liabilities
The following table sets forth by level, within the fair value hierarchy, the Company’s assets and liabilities measured and recorded at fair value on a recurring basis (in thousands):
March 31, 2024December 31, 2023
Level 1Level 2Level 1Level 2
Assets
Cash equivalents(1)
$3,037,792 $— $3,682,917 $— 
Customer custodial funds(2)
4,894,429 — 3,301,029 — 
Crypto asset loan receivables
— 196,141 — 22,229 
Crypto assets borrowed(3)
231,348 — 45,212 — 
Safeguarding customer crypto assets— 329,506,477 — 192,583,060 
Derivative assets(4)
— 44,214 — 30,577 
Crypto assets held for operations150,630 — 74,103 — 
Crypto assets held as collateral106,610 — — — 
Crypto assets held for investment1,522,328 — 330,610 — 
Total assets$9,943,137 $329,746,832 $7,433,871 $192,635,866 
Liabilities
Safeguarding customer crypto liabilities$— $329,506,477 $— $192,583,060 
Derivative liabilities(4)
— 150,104 — 21,913 
Obligation to return collateral106,610 — — — 
Total liabilities$106,610 $329,656,581 $— $192,604,973 
__________________
(1)Represents money market funds. Excludes $3.5 billion of corporate cash held in deposit at banks and $124.8 million held at venues, which were not measured and recorded at fair value as of March 31, 2024. Excludes $1.4 billion of corporate cash held in deposit at banks and $88.8 million held at venues, which were not measured and recorded at fair value as of December 31, 2023.
(2)Represents money market funds. Excludes customer custodial funds of $307.5 million and $1.3 billion held in deposit at financial institutions and not measured and recorded at fair value as of March 31, 2024 and December 31, 2023, respectively.
(3)Includes crypto assets held that were designated as hedged items in fair value hedges as of December 31, 2023 and excludes crypto assets of $404.7 million held at cost as of December 31, 2023.
(4)See Note 13. Derivatives for additional details.